ALYSSA G RIEBER M.D. NPI 1639265796

NPI Details

Alyssa G Rieber, M.D. is a hematology and oncology internal medicine in Fredericksburg, TX with 25 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Alyssa G Rieber, M.D. NPI is 1639265796. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE
Graduation Year:2001

The provider's business location address is:

506 W WINDCREST ST STE 300
FREDERICKSBURG, TX
ZIP 78624-639
Phone: (830) 990-0255
Fax: (830) 997-7569

The NPI 1639265796 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Protein measurement, serum (HCPCS:84165)
• Uric acid level, blood (HCPCS:84550)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Unclassified drugs (HCPCS:J3490)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Folic acid level, serum (HCPCS:82746)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Drawing of blood for a medical problem (HCPCS:99195)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Reticulated (young) platelet measurement (HCPCS:85055)
• Magnesium level (HCPCS:83735)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Phosphate level (HCPCS:84100)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Injection, alteplase recombinant, 1 mg (HCPCS:J2997)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Blood test, clotting time (HCPCS:85610)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Injection of drug or substance into vein (HCPCS:96374)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Testosterone (hormone) level, total (HCPCS:84403)
• Declotting of central venous tube (HCPCS:36593)
• Alpha-fetoprotein (afp) level, serum (HCPCS:82105)
• Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Nuclear medicine study whole body with ct scan (HCPCS:78816)
• Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)

The enumeration date for this NPI number is 10/5/2006 and was last updated on 1/15/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.